In conclusion, our data showed that combined stimulation through IL-2 and 4-1BB receptors with IL-2 from IL-2 cDNA and anti-4-1BB Abs, respectively, is critical for increasing tumor cure rates induced by E7 DNA vaccines. This evidence concerns the gene TNFRSF9 and neoplasm.